Fan Zou

99 Ziyang Road
Wuhan, 430060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage-myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis.

BMAL1 regulates tubular epithelial-derived exosomal miR-27a-3p to inhibit macrophage-myofibroblast transition and alleviate ischemia/reperfusion-induced renal fibrosis.

Journal: Theranostics

Published: October 29, 2025

Genetic Associations Between Specific Sleep-Related Phenotypes and Idiopathic Sudden Sensorineural Hearing Loss: A Mendelian Randomization Analysis.

Genetic Associations Between Specific Sleep-Related Phenotypes and Idiopathic Sudden Sensorineural Hearing Loss: A Mendelian Randomization Analysis.

Journal: Nature and science of sleep

Published: August 20, 2024

Harnessing Natural Pollen as Sustained-Release, Mucoadhesive, and Biosafe Drug Microcapsules for Intravesical Instillation in Bladder Cancer Treatment.

Harnessing Natural Pollen as Sustained-Release, Mucoadhesive, and Biosafe Drug Microcapsules for Intravesical Instillation in Bladder Cancer Treatment.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: July 26, 2024

AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.

AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.

Journal: Journal of translational medicine

Published: December 04, 2023

EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression.

EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression.

Journal: Journal of translational medicine

Published: September 27, 2023

Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progression.

Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progression.

Journal: Cancer medicine

Published: August 23, 2023

BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.

BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.

Journal: International immunopharmacology

Published: August 10, 2023

DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.

DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.

Journal: Cellular signalling

Published: August 06, 2023

FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression.

FAM171B stabilizes vimentin and enhances CCL2-mediated TAM infiltration to promote bladder cancer progression.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 21, 2023

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker.

Journal: Aging

Published: May 15, 2023

Prognostic and immunological roles of IL18RAP in human cancers.

Prognostic and immunological roles of IL18RAP in human cancers.

Journal: Aging

Published: May 06, 2023

MTHFD2 promotes PD-L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer.

MTHFD2 promotes PD-L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer.

Journal: Journal of cellular and molecular medicine

Published: March 26, 2023

Showing 1-12 of 15

Last Updated: 09/26/2026